醫思健康(02138.HK)年度總收入達41.40億港元 股東應佔虧損擴大至1.67億港元
格隆匯6月19日丨醫思健康(02138.HK)公佈年度業績,截至2025年3月31日止年度,公司總收入爲41.402億港元,同比減少1.7%;公司股東應佔虧損1.672億港元,上年同期虧損1894.7萬港元,每股虧損14.1港仙。
報告期期內,集團產生收入41.40億港元,銷售額爲41.70億港元,同比分別輕微減少1.7%及1.0%,反映兩項主要因素:(1)受深圳跨境醫療保健服務消費者謹慎消費及日益增長的趨勢影響,包括醫療服務、醫美療程及美容保健產品在內的非必需醫療保健服務分部需求疲軟;及(2)透過策略性出售若幹醫療資產,針對性優化投資組合,加強資本管理,並透過主動管理資產負債表創造價值。
在維持高服務水平的同時,集團始終維持嚴格的成本管理及策略整合,以適應市場環境。經調整後,倘剔除下列影響:(i)出售附屬公司的收益淨額;(ii)政府補助;(iii)按公平值計量的金融資產虧損;(iv)商譽減值虧損;(v)投資物業公平值虧損;(vi)合營企業減值虧損;(vii)其他應收款項減值虧損;(viii)分佔一間聯營公司的減值虧損及(ix)出售及撇銷物業、廠房及設備的虧損,集團於報告期間的經調整息稅折舊及攤銷前之盈利同比減少15.1%至3.752億港元,反映市場挑戰以及我們對長期營運效率的策略投資。該等措施使集團的表現在市場環境趨於穩定下有所提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.